[go: up one dir, main page]

FR2920158B1 - Production de plasmides et expression de proteines recombinantes dans des cellules cultivees sans antibiotiques - Google Patents

Production de plasmides et expression de proteines recombinantes dans des cellules cultivees sans antibiotiques

Info

Publication number
FR2920158B1
FR2920158B1 FR0757175A FR0757175A FR2920158B1 FR 2920158 B1 FR2920158 B1 FR 2920158B1 FR 0757175 A FR0757175 A FR 0757175A FR 0757175 A FR0757175 A FR 0757175A FR 2920158 B1 FR2920158 B1 FR 2920158B1
Authority
FR
France
Prior art keywords
antibiotics
expression
recombinant proteins
cultivated cells
plasmid production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0757175A
Other languages
English (en)
Other versions
FR2920158A1 (fr
Inventor
Daniel Scherman
Corinne Marie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Universite Paris Cite
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Universite Paris Descartes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut National de la Sante et de la Recherche Medicale INSERM, Universite Paris Descartes filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0757175A priority Critical patent/FR2920158B1/fr
Priority to JP2010521443A priority patent/JP2010536361A/ja
Priority to CA2697498A priority patent/CA2697498A1/fr
Priority to PCT/EP2008/061045 priority patent/WO2009027351A1/fr
Priority to US12/675,011 priority patent/US8440455B2/en
Priority to EP08787440A priority patent/EP2195434A1/fr
Publication of FR2920158A1 publication Critical patent/FR2920158A1/fr
Application granted granted Critical
Publication of FR2920158B1 publication Critical patent/FR2920158B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0757175A 2007-08-24 2007-08-24 Production de plasmides et expression de proteines recombinantes dans des cellules cultivees sans antibiotiques Active FR2920158B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0757175A FR2920158B1 (fr) 2007-08-24 2007-08-24 Production de plasmides et expression de proteines recombinantes dans des cellules cultivees sans antibiotiques
JP2010521443A JP2010536361A (ja) 2007-08-24 2008-08-22 抗生物質不在下で増殖した細胞における組換え蛋白質の原形質での産生および発現
CA2697498A CA2697498A1 (fr) 2007-08-24 2008-08-22 Production de plasmides et expression de proteines recombinantes dans des cellules cultivees sans antibiotiques
PCT/EP2008/061045 WO2009027351A1 (fr) 2007-08-24 2008-08-22 Production de plasmides et expression de proteines recombinantes dans des cellules cultivees sans antibiotiques
US12/675,011 US8440455B2 (en) 2007-08-24 2008-08-22 Plasmic production and expression of recombinant proteins in cells grown without antibiotics
EP08787440A EP2195434A1 (fr) 2007-08-24 2008-08-22 Production de plasmides et expression de proteines recombinantes dans des cellules cultivees sans antibiotiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0757175A FR2920158B1 (fr) 2007-08-24 2007-08-24 Production de plasmides et expression de proteines recombinantes dans des cellules cultivees sans antibiotiques

Publications (2)

Publication Number Publication Date
FR2920158A1 FR2920158A1 (fr) 2009-02-27
FR2920158B1 true FR2920158B1 (fr) 2010-03-12

Family

ID=39111557

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0757175A Active FR2920158B1 (fr) 2007-08-24 2007-08-24 Production de plasmides et expression de proteines recombinantes dans des cellules cultivees sans antibiotiques

Country Status (6)

Country Link
US (1) US8440455B2 (fr)
EP (1) EP2195434A1 (fr)
JP (1) JP2010536361A (fr)
CA (1) CA2697498A1 (fr)
FR (1) FR2920158B1 (fr)
WO (1) WO2009027351A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2547768B1 (fr) 2010-03-17 2015-12-30 Association Institut de Myologie Snarn u7 modifiés pour traiter les maladies neuromusculaires
US9403880B2 (en) 2010-11-26 2016-08-02 Institut Pasteur Identification of a human gyrovirus and applications
EP2788477A2 (fr) 2011-12-07 2014-10-15 Institut Pasteur Identification d'un virus porcin de type paréchovirus et applications
EP2796556A1 (fr) 2013-04-25 2014-10-29 Rijksuniversiteit Groningen Moyens et procédés améliorés permettant d'exprimer des protéines de recombinaison
WO2020077010A1 (fr) * 2018-10-09 2020-04-16 Second Genome, Inc. Système d'expression de lactococcus lactis pour l'administration de protéines efficaces pour le traitement de troubles de la fonction barrière épithéliale
EP3670652A1 (fr) 2018-12-18 2020-06-24 NEUWAY Pharma GmbH Vlp pour le traitement d'une maladie de stockage lysosomal
EP3688147B8 (fr) 2018-12-18 2022-10-26 NEUWAY Pharma GmbH Nouveau système d'administration de médicament et ses procédés de fourniture
JP2023526528A (ja) 2020-05-22 2023-06-21 ノイウェイ ファルマ ゲーエムベーハー 白質ジストロフィーの処置のためのｖｌｐ
KR20230066000A (ko) * 2020-08-12 2023-05-12 액팀 테라퓨틱스, 인코퍼레이티드 면역자극성 박테리아-기초 백신, 치료제, 및 rna 전달 플랫폼

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3584341D1 (de) * 1984-08-24 1991-11-14 Upjohn Co Rekombinante dna-verbindungen und expression von polypeptiden wie tpa.
US7279313B2 (en) * 1995-09-15 2007-10-09 Centelion Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
SK18322000A3 (sk) * 1998-06-02 2001-11-06 Glaxo Group Limited Použitie molekuly nukleovej kyseliny, farmaceutický prostriedok s jej obsahom a molekula nukleovej kyseliny

Also Published As

Publication number Publication date
US8440455B2 (en) 2013-05-14
WO2009027351A1 (fr) 2009-03-05
FR2920158A1 (fr) 2009-02-27
US20110129487A1 (en) 2011-06-02
JP2010536361A (ja) 2010-12-02
CA2697498A1 (fr) 2009-03-05
EP2195434A1 (fr) 2010-06-16

Similar Documents

Publication Publication Date Title
FR2920158B1 (fr) Production de plasmides et expression de proteines recombinantes dans des cellules cultivees sans antibiotiques
DK2516471T4 (da) Kimære polypeptider og deres anvendelse i bakteriel dekolonisering
EP2414548A4 (fr) Analyse de l'expression génétique dans des cellules individuelles
HUE036759T2 (hu) CRY1Ca és CRY1Fa proteinek kombinált alkalmazása rovarrezisztencia menedzselésére
EP2263089A4 (fr) Affichage en surface de protéines recombinantes dans des eucaryotes inférieurs
EP2506857A4 (fr) Administration d'arnm pour l'augmentation des protéines et des enzymes dans des maladies génétiques humaines
IL207671A0 (en) Optimisation of expression of parvoviral rep and cap proteins in insect cells
EP2408795A4 (fr) Production de protéines dans des micro-organismes de phylum labyrinthulomycota
EP1725251A4 (fr) Incorporation selective de 5-hydroxytryptophane dans des proteines dans des cellules mammaliennes
DK2007884T3 (da) Cellulasefusionsproteiner og deres anvendelse
IL202213A0 (en) Recombinant protein production in avian ebxr cells
BRPI0918027A2 (pt) enzimas de lise de peptidoglicano artificial e proteínas de ligação de peptidoglicano
IL266122A (en) Stable serum-free cell-to-cell gene transfer and production of recombinant human proteins in human cell lines
EP2300611A4 (fr) Programmation et reprogrammation des cellules
EP2525649A4 (fr) Excision de transgènes dans organismes génétiquement modifiés
EP2356134A4 (fr) Stimulation optique de cellules cibles et modifications de celles-ci
EP2547771A4 (fr) Production de protéines et de polypeptides
EP1910516A4 (fr) Culture en suspension de cellules souches embryonnaires humaines
HUE039070T2 (hu) Új szignálszekvenciák fehérje-expresszió és rekombináns enzimek és más fehérjék szekréciójának javítására
EP2655651A4 (fr) Procédé peu coûteux d'expression et purification de protéines recombinantes dans des plantes
EP2519636A4 (fr) Production de protéine hémagglutinine-neuraminidase dans des microalgues
SMT201600147B (it) Metodi per migliorare l'espressione di proteine ricombinanti
EP2043677A4 (fr) Combinaisons de protéines humaines destinées à accroître la viabilité de cellules souches et de cellules progénitrices
FR2932388B1 (fr) Nouvelles proteines de fusion et leur application pour la preparation de vaccins contre l'hepatite c
EP2408926A4 (fr) Production de protéines de recombinaison dans des ciliés et leurs utilisations

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

CD Change of name or company name

Owner name: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERC, FR

Effective date: 20221006

Owner name: UNIVERSITE PARIS CITE, FR

Effective date: 20221006

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE -, FR

Effective date: 20221006

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19